FMP
Divi's Laboratories Limited
DIVISLAB.NS
NSE
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.
3911.4 INR
-51.6001 (-1.32%)
About
ceo
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.divislabs.com
exchange
NSE
Description
Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.
CIK
N/A
ISIN
INE361B01024
CUSIP
Y2076F112
Address
Divi Towers
Phone
91 40 6696 6300
Country
IN
Employee
8,433
IPO Date
Mar 12, 2003
Key Executives
